TP53 and cancer: Finally, with respect to the second objective, we report one novel scaffold of high originality and a promising bioactivity profile in terms of CK1 inhibition and selectivity, and we demonstrate the inhibitor potential to modulate the levels of downstream to CK1 DDR-related tumor suppressor p53 in cancer cells.